Pain Medicine, Interventional Pain Medicine · Trinity, FL
NPI
1124089354
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
8146 Cerebellum Way Ste 102
Trinity, FL, 34655
Phone (727) 264-8865
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
5,394 services
Medicare patients, 2024
257
Average age 73
Drug cost, 2024
$713K
13,430 prescriptions
Company payments, 2025
$19.41
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anjan K Ghosh was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 3,127 times for 132 patients. In total Anjan K Ghosh billed 5,394 services in 35 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,127 | 132 | $0.09 | $276 |
| 99214 Office E&M - Established | Office | 1,397 | 236 | $89.25 | $125K |
| 80305 Drug Tests | Office | 201 | 192 | $12.30 | $2,471 |
| 99213 Office E&M - Established | Office | 108 | 66 | $61.86 | $6,681 |
| 99203 Office E&M - New | Office | 61 | 61 | $76.36 | $4,658 |
| 20610 Joint Injection | Office | 49 | 34 | $56.69 | $2,778 |
| 27096 Joint Injection | Office | 42 | 34 | $152.78 | $6,417 |
| 64483 Nerve Block Injection - Back | Office | 38 | 28 | $205.91 | $7,825 |
| 64494 Nerve Block Injection - Back | Office | 37 | 23 | $100.69 | $3,725 |
| 64493 Nerve Block Injection - Back | Office | 37 | 23 | $185.11 | $6,849 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 29 | 24 | $255.52 | $7,410 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 28 | 24 | $478.87 | $13K |
| 20552 Musculoskeletal | Office | 28 | 21 | $36.77 | $1,030 |
| 62323 Nerve Block Injection - Back | Office | 22 | 16 | $195.09 | $4,292 |
| 64490 Nerve Block Injection - Back | Office | 21 | 15 | $176.79 | $3,713 |
By year: 2022 $12K for 112 services; 2023 $160K for 4,365 services; 2024 $211K for 5,394 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 201 | 192 | $12.30 | $2,471 |
Medicare prescription drug claims, 2024
In 2024, the drug Anjan K Ghosh prescribed most often to Medicare patients was Oxycodone Hcl, with 2,052 prescriptions and refills. In total Anjan K Ghosh wrote 13,430 Medicare prescriptions that cost $713K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 2,052 | 2,052 | 277 | $50K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,807 | 1,807 | 305 | $47K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,588 | 1,588 | 251 | $60K |
| Morphine Sulfate Er Morphine Sulfate | 1,433 | 1,433 | 191 | $43K |
| Tizanidine Hcl Generic | 924 | 1,075 | 179 | $11K |
| Gabapentin Generic | 817 | 967 | 165 | $8,638 |
| Tramadol Hcl Generic | 590 | 591 | 113 | $6,759 |
| Pregabalin Generic | 537 | 573 | 97 | $7,745 |
| Meloxicam Generic | 293 | 363 | 71 | $952 |
| Hydromorphone Hcl Generic | 289 | 289 | 61 | $8,574 |
| Cyclobenzaprine Hcl Generic | 250 | 283 | 57 | $2,106 |
| Xtampza Er Oxycodone Myristate | 188 | 188 | 37 | $130K |
| Methylprednisolone Generic | 182 | 182 | 137 | $1,378 |
| Fentanyl Generic | 176 | 176 | 23 | $17K |
| Zolpidem Tartrate Generic | 174 | 186 | 27 | $1,085 |
Brand drugs: 664 claims; generic drugs: 12,766 claims; opioid claims: 8,555.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anjan K Ghosh $19.41 ($19.41 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $19.41.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $19.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.